What Steps Need to be Taken to Increase Prescriber Uptake of Biosimilars?

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how to increase the utilization of biosimilars across the industry.

Ogurchak: Biosimilars are a new thing in the specialty industry, and there’s really only a handful that have been approved by the FDA to date. So, in order for those to grow across the industry and have additional utilization by prescribers, education is going to be crucial. There’s going to be a need for doctors to know what is out there, how they can prescribe for them, how payers are going to respond, alike, because this is an uncharted territory for prescribers. They really haven’t seen anything in the generics space, if you will, to date. So the education of how to utilize, how to best demonstrate outcomes as opposed to the legend product is going to be key.